STOCK TITAN

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PROCEPT BioRobotics (Nasdaq: PRCT), a surgical robotics company specializing in urology solutions, has announced its participation in the 2024 Wells Fargo Healthcare Conference in Boston. The company's management team is scheduled to present on Wednesday, September 4, 2024, at 1:30 p.m. Eastern Time.

Investors and interested parties can access a live webcast of the presentation through the company's website at https://ir.procept-biorobotics.com. The webcast will also be archived for at least 90 days after the event, allowing for later viewing. This presentation offers an opportunity for PROCEPT BioRobotics to showcase its innovative urological solutions and connect with healthcare industry professionals and investors.

PROCEPT BioRobotics (Nasdaq: PRCT), un'azienda di robotica chirurgica specializzata in soluzioni per l'urologia, ha annunciato la sua partecipazione alla Wells Fargo Healthcare Conference 2024 a Boston. Il team di gestione dell'azienda presenterà mercoledì 4 settembre 2024, alle ore 13:30, ora orientale.

Gli investitori e le parti interessate potranno accedere a un webcast dal vivo della presentazione tramite il sito web dell'azienda all'indirizzo https://ir.procept-biorobotics.com. Il webcast sarà archiviato per almeno 90 giorni dopo l'evento, consentendo una visione successiva. Questa presentazione offre a PROCEPT BioRobotics l'opportunità di mostrare le sue innovative soluzioni urologiche e di connettersi con professionisti del settore sanitario e investitori.

PROCEPT BioRobotics (Nasdaq: PRCT), una empresa de robótica quirúrgica especializada en soluciones de urología, ha anunciado su participación en la Conferencia de Salud de Wells Fargo 2024 en Boston. El equipo de gestión de la compañía está programado para presentar el miércoles 4 de septiembre de 2024, a la 1:30 p.m., hora del Este.

Los inversores y partes interesadas pueden acceder a un webcast en vivo de la presentación a través del sitio web de la empresa en https://ir.procept-biorobotics.com. El webcast también se archivará durante al menos 90 días después del evento, permitiendo su visualización posterior. Esta presentación ofrece a PROCEPT BioRobotics la oportunidad de mostrar sus innovadoras soluciones urológicas y de conectarse con profesionales de la industria de la salud e inversores.

PROCEPT BioRobotics (Nasdaq: PRCT)는 비뇨기학 솔루션을 전문으로 하는 외과 로봇 회사로, 보스턴에서 열리는 2024 웰스 파고 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사의 관리팀은 2024년 9월 4일 수요일 오후 1시 30분 동부 표준시에 발표할 예정입니다.

투자자 및 이해당사자는 회사 웹사이트 https://ir.procept-biorobotics.com를 통해 발표의 실시간 웹캐스트에 접속할 수 있습니다. 웹캐스트는 이벤트 후 최소 90일 동안 아카이브됩니다, 나중에 다시 볼 수 있습니다. 이 발표는 PROCEPT BioRobotics가 혁신적인 비뇨기 솔루션을 선보이고 헬스케어 산업 전문가 및 투자자들과 연결할 수 있는 기회를 제공합니다.

PROCEPT BioRobotics (Nasdaq: PRCT), une entreprise de robotique chirurgicale spécialisée dans les solutions en urologie, a annoncé sa participation à la Conférence Santé Wells Fargo 2024 à Boston. L'équipe de direction de l'entreprise doit présenter le mercredi 4 septembre 2024 à 13h30, heure de l'Est.

Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via le site web de l'entreprise à l'adresse https://ir.procept-biorobotics.com. Le webinaire sera également archivé pendant au moins 90 jours après l'événement, permettant ainsi une consultation ultérieure. Cette présentation offre à PROCEPT BioRobotics l'opportunité de présenter ses solutions urologiques innovantes et de se connecter avec des professionnels du secteur de la santé et des investisseurs.

PROCEPT BioRobotics (Nasdaq: PRCT), ein Unternehmen für chirurgische Robotik, das auf urologische Lösungen spezialisiert ist, hat seine Teilnahme an der Wells Fargo Healthcare Conference 2024 in Boston angekündigt. Das Managementteam des Unternehmens wird am Mittwoch, den 4. September 2024, um 13:30 Uhr Eastern Time präsentieren.

Investoren und interessierte Parteien können über die Unternehmenswebsite https://ir.procept-biorobotics.com auf einen Live-Webcast der Präsentation zugreifen. Der Webcast wird auch mindestens 90 Tage nach der Veranstaltung archiviert, sodass eine spätere Ansicht möglich ist. Diese Präsentation bietet PROCEPT BioRobotics die Möglichkeit, seine innovativen urologischen Lösungen zu präsentieren und sich mit Fachleuten der Gesundheitsbranche sowie Investoren zu vernetzen.

Positive
  • None.
Negative
  • None.

SAN JOSE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Wells Fargo Healthcare Conference in Boston, Massachusetts. Management is scheduled to present on Wednesday, September 4 at 1:30 p.m. Eastern Time.

A live webcast of each event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The HYDROSTM Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.

Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com


FAQ

When is PROCEPT BioRobotics (PRCT) presenting at the 2024 Wells Fargo Healthcare Conference?

PROCEPT BioRobotics (PRCT) is scheduled to present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 1:30 p.m. Eastern Time.

Where can I watch the PROCEPT BioRobotics (PRCT) presentation at the Wells Fargo Healthcare Conference?

You can watch a live webcast of the PROCEPT BioRobotics (PRCT) presentation on the 'Investors' section of the company's website at https://ir.procept-biorobotics.com.

How long will the PROCEPT BioRobotics (PRCT) webcast be available after the Wells Fargo Healthcare Conference?

The webcast of PROCEPT BioRobotics' (PRCT) presentation will be archived and available for replay for at least 90 days after the event.

What is the focus of PROCEPT BioRobotics (PRCT) as a company?

PROCEPT BioRobotics (PRCT) is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology.

PROCEPT BioRobotics Corporation

NASDAQ:PRCT

PRCT Rankings

PRCT Latest News

PRCT Stock Data

4.24B
51.93M
5.05%
87.88%
10.92%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN JOSE